BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06961331-completion@plaintrial.com
DTSTAMP:20261028T192654Z
DTSTART;VALUE=DATE:20250925
SUMMARY:Real World-clinical Outcomes of Tucatinib\, Trastuzumab\, and Capec
 itabine Following Trastuzumab Deruxtecan (T-DXd) for the Treatment of HER2
 -positive Metastatic Breast Cancer. — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT06961331
URL:https://plaintrial.com/trial/NCT06961331
END:VEVENT
END:VCALENDAR